ArrowMark Colorado Holdings’s Procept Biorobotics PRCT Stock Holding History

ArrowMark Colorado Holdings’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,349,831	Closed	-$42.5M	–	317
2025 Q4	$42.5M	Buy	1,349,831 +221,543	+20%	+$7.35M	0.93%	33
2025 Q3	$40.3M	Buy	1,128,288 +786,094	+230%	+$35.9M	0.75%	43
2025 Q2	$19.7M	Buy	+342,194	New	+$19.3M	0.35%	81
2024 Q3	–	Sell	-69,471	Closed	-$4.24M	–	327
2024 Q2	$4.24M	Sell	69,471 -48,493	-41%	-$2.88M	0.05%	215
2024 Q1	$5.83M	Sell	117,964 -18,736	-14%	-$892K	0.07%	198
2023 Q4	$5.73M	Buy	136,700 +25,086	+22%	+$854K	0.06%	196
2023 Q3	$3.66M	Buy	+111,614	New	+$3.81M	0.04%	207

Other funds holding PRCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ArrowMark Colorado Holdings's PRCT Position: Q1 2026 in Review

ArrowMark Colorado Holdings sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 1,349,831 shares — an estimated $42.5M sold.

ArrowMark Colorado Holdings first reported a position in PRCT in Q3 2023 and held it in 7 quarters. The position peaked at $42.5M in Q4 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

ArrowMark Colorado Holdings reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
ArrowMark Colorado Holdings sold 1,349,831 Procept Biorobotics shares in Q1 2026, an estimated $42.5M.
ArrowMark Colorado Holdings first reported a position in Procept Biorobotics in Q3 2023 and held it in 7 quarters.
ArrowMark Colorado Holdings's Procept Biorobotics position peaked at $42.5M in Q4 2025.
256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.